Figures & data
Figure 1. Preoperative diagnosis of main duct IPMN. (A) MRI scan showing a universally dilated main pancreatic duct (arrows) in head, body and tail. (B) CT scan showing a 42 mm mass in the pancreatic head (arrow) and (C) an atrophic pancreatic body and tail with dilated duct (arrow).
![Figure 1. Preoperative diagnosis of main duct IPMN. (A) MRI scan showing a universally dilated main pancreatic duct (arrows) in head, body and tail. (B) CT scan showing a 42 mm mass in the pancreatic head (arrow) and (C) an atrophic pancreatic body and tail with dilated duct (arrow).](/cms/asset/856bc589-7c29-401f-9bc8-1fc0d5a56bfd/igas_a_2197095_f0001_b.jpg)
Figure 2. Histomorphological findings of an IPMN. (A) The IPMN is shown in the main pancreatic duct (arrow), with (B) positive staining for epithelial marker cytokeratin (CK)-19. Encircled area resembles the area for the immunohistochemistry markers to the right (middle column). (C) Part with invasive pancreatic adenocarcinoma and high-grade dysplasia in the pancreatic resection margin (inlets). (D) Areas of Pancreatic Intraepithelial Neoplasia (PanIN), with loss of cytokeratin-20, an epithelial marker. Presented to the annual meeting of the Norwegian Society of Pathology (Bergen, December 2004).
![Figure 2. Histomorphological findings of an IPMN. (A) The IPMN is shown in the main pancreatic duct (arrow), with (B) positive staining for epithelial marker cytokeratin (CK)-19. Encircled area resembles the area for the immunohistochemistry markers to the right (middle column). (C) Part with invasive pancreatic adenocarcinoma and high-grade dysplasia in the pancreatic resection margin (inlets). (D) Areas of Pancreatic Intraepithelial Neoplasia (PanIN), with loss of cytokeratin-20, an epithelial marker. Presented to the annual meeting of the Norwegian Society of Pathology (Bergen, December 2004).](/cms/asset/2c5d70ef-bca5-4e3b-a649-fabaac47cd61/igas_a_2197095_f0002_c.jpg)